Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma

Muhamad Alhaj Moustafa, Jennifer Peterson, Bradford S. Hoppe, Jennifer Jiang, Gregory A. Wiseman, Thomas E. Witzig, Han W. Tun

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences